MARKET

NNVC

NNVC

NANOVIRICIDES
AMEX

Real-time Quotes | Nasdaq Last Sale

4.020
-0.060
-1.47%
After Hours: 4.030 +0.01 +0.25% 19:32 09/17 EDT
OPEN
3.920
PREV CLOSE
4.080
HIGH
4.170
LOW
3.920
VOLUME
377.88K
TURNOVER
--
52 WEEK HIGH
8.71
52 WEEK LOW
2.850
MARKET CAP
46.25M
P/E (TTM)
-4.6853
1D
5D
1M
3M
1Y
5Y
YY, NNVC and REKR among mid-day movers
Gainers: GreenSky (NASDAQ:GSKY) +53%. IronNet (NYSE:IRNT) +27%. Sphere (NASDAQ:ANY) +22%. Allied Healthcare Products (NASDAQ:AHPI) +19%. Actinium Pharmaceuticals (NYSE:ATNM) +16%. Ampio Pharmaceuticals (NYSE:AMPE) +15%. Inozyme Pharma (NASDAQ:INZY) +15%. S...
Seekingalpha · 2d ago
38 Stocks Moving In Wednesday's Mid-Day Session
Gainers Indaptus Therapeutics, Inc. (NASDAQ: INDP) shares jumped 177.2% to $19.60 after the company announced the United States Patent and Trademark Office has issued a notice of allowance for claims related to the company's platform technology.
Benzinga · 2d ago
Ampio Pharmaceuticals, 180 Life Sciences leads healthcare gainers; Nuwellis, Berkeley Lights among major losers
Gainers: Ampio Pharmaceuticals (NYSE:AMPE) +22%, 180 Life Sciences (NASDAQ:ATNF) +17%, Brainstorm Cell Therapeutics (NASDAQ:BCLI) +15%, Instil Bio (NASDAQ:TIL) +16%, G Medical Innovations (NASDAQ:GMVD) +15%. Losers: Nuwellis (NASDAQ:NUWE) -26%, Berkeley Li...
Seekingalpha · 2d ago
Why Nanoviricides' Stock Is Trading Higher Today
Nanoviricides (AMEX:NNVC) shares are trading higher after the company announced it completed the process of licensing the human Coronavirus field for drug development and commercialization from TheraCour Pharma, Inc.
Benzinga · 3d ago
36 Stocks Moving In Tuesday's Mid-Day Session
Gainers FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results. BELLUS Health Inc. (NASDAQ: BLU) shares climbed 25.5% to $6.00. The company on Monday announced interim analysis from the Ph...
Benzinga · 3d ago
BELLUS Health, aTyr Pharma leads healthcare gainers; Virpax Pharmaceuticals, RedHill Biopharma among major losers
Gainers: BELLUS Health (NASDAQ:BLU) +26%, aTyr Pharma (NASDAQ:LIFE) +22%, Jounce Therapeutics (NASDAQ:JNCE) +14%, NanoViricides (NYSE:NNVC) +12%, Matinas BioPharma (NYSE:MTNB) +12%. Losers: Virpax Pharmaceuticals (NASDAQ:VRPX) -37%, RedHill Biopharma (NASD...
Seekingalpha · 3d ago
Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Sept. 14, 2021: LEN, LICD, HLF, NNVC, PROG
Today's 5 Stock Ideas:  Lennar Corp (LEN) - Lennar reports Q3 earnings on Monday, September 20th. Lucid Group (LCID) - Shares down ~4.40% premarket. Morgan Stanley initiated coverage on the stock
Benzinga · 3d ago
NNVC, LIFE and DATS pre market gainers
Communications Systems JCS +27% declares $3.50 special dividend NanoViricides (NYSE:NNVC) +21% completes licensing for Coronavirus field which includes current COVID-19 drug development aTyr Pharma (NASDAQ:LIFE) +13%. DatChat (NASDAQ:DATS) +10%. SeaChange ...
Seekingalpha · 3d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NNVC. Analyze the recent business situations of NANOVIRICIDES through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NNVC stock price target is 14.50 with a high estimate of 14.50 and a low estimate of 14.50.
EPS
Institutional Holdings
Institutions: 38
Institutional Holdings: 3.05M
% Owned: 26.48%
Shares Outstanding: 11.51M
TypeInstitutionsShares
Increased
3
85.77K
New
2
25.06K
Decreased
6
173.75K
Sold Out
4
1.42M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.49%
Pharmaceuticals & Medical Research
-0.10%
Key Executives
Chairman/President/Executive Director
Anil Diwan
Chief Financial Officer
Meeta Vyas
Independent Director
Stanley Glick
Independent Director
Makarand Jawadekar
Independent Director
Theodore Rokita
Independent Director
Brian Zucker
No Data
About NNVC
NanoViricides, Inc. is a nano-biopharmaceutical company. The Company is engaged in discovery, development, and commercialization of drugs to combat viral infections using its nanomedicines technology. The Company's nanoviricide technology enables direct attacks at multiple points on a virus particle. The nanomedicines technology also enables attacking the rapid intracellular reproduction of the virus by incorporating one or more active pharmaceutical ingredients (APIs) within the core of the nanoviricide. The Company is developing antiviral drug candidate, NV-CoV-2 drug for the treatment of COVID-19 infected sick persons. Its other clinical drug candidate NV-HHV-101 a skin cream for the treatment of shingles rash.

Webull offers kinds of NanoViricides Inc stock information, including AMEX:NNVC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NNVC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NNVC stock methods without spending real money on the virtual paper trading platform.